Elisa Kasbohm

Ms. Elisa Kasbohm

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Nature
Verified
Journal Article
Open access
KHKonstantinos Hatzikotoulas
Konstantinos Hatzikotoulas
LSLorraine Southam
Lorraine Southam
LSLilja Stefansdottir
Lilja Stefansdottir
CBCindy G. Boer
Cindy G. Boer
MMMerry-Lynn McDonald
Merry-Lynn McDonald
EZEleftheria Zeggini
Eleftheria Zeggini
Osteoarthritis is the third most rapidly growing health condition associated with disability, after dementia and diabetes1. By 2050, the total number of patients with osteoarthritis is estimated to reach 1 billion worldwide2. As no disease-modifying treatments exist for osteoarthritis, a better understanding of disease aetiopathology is urgently needed. Here we perform a genome-wide association study meta-analyses across up to 489,975 cases and 1,472,094 controls, establishing 962 independent associations, 513 of which have not been previously reported. Using single-cell multiomics data, we identify signal enrichment in embryonic skeletal development pathways. We integrate orthogonal lines of evidence, including transcriptome, proteome and epigenome profiles of primary joint tissues, and implicate 700 effector genes. Within these, we find rare coding-variant burden associations with effect sizes that are consistently higher than common frequency variant associations. We highlight eight biological processes in which we find convergent involvement of multiple effector genes, including the circadian clock, glial-cell-related processes and pathways with an established role in osteoarthritis (TGFβ, FGF, WNT, BMP and retinoic acid signalling, and extracellular matrix organization). We find that 10% of the effector genes express a protein that is the target of approved drugs, offering repurposing opportunities, which can accelerate translation.

22 April 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
JMJoany Mariño
Joany Mariño
EKElisa Kasbohm
Elisa Kasbohm
SSStephan Struckmann
Stephan Struckmann
LKLorenz A. Kapsner
Lorenz A. Kapsner
CSCarsten Oliver Schmidt
Carsten Oliver Schmidt
Data quality assessments (DQA) are necessary to ensure valid research results. Despite the growing availability of tools of relevance for DQA in the R language, a systematic comparison of their functionalities is missing. Therefore, we review R packages related to data quality (DQ) and assess their scope against a DQ framework for observational health studies. Based on a systematic search, we screened more than 140 R packages related to DQA in the Comprehensive R Archive Network. From these, we selected packages which target at least three of the four DQ dimensions (integrity, completeness, consistency, accuracy) in a reference framework. We evaluated the resulting 27 packages for general features (e.g., usability, metadata handling, output types, descriptive statistics) and the possible assessment’s breadth. To facilitate comparisons, we applied all packages to a publicly available dataset from a cohort study. We found that the packages’ scope varies considerably regarding functionalities and usability. Only three packages follow a DQ concept, and some offer an extensive rule-based issue analysis. However, the reference framework does not include a few implemented functionalities, and it should be broadened accordingly. Improved use of metadata to empower DQA and user-friendliness enhancement, such as GUIs and reports that grade the severity of DQ issues, stand out as the main directions for future developments.

9 November 2022 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
GWGesine F.C. Weckmann
Gesine F.C. Weckmann
JWJanine Wirkner
Janine Wirkner
EKElisa Kasbohm
Elisa Kasbohm
CZCarolin Zimak
Carolin Zimak
AHAnnekathrin Haase
Annekathrin Haase
Sylvia StrackeSylvia Stracke
Sylvia Stracke
Background: Although chronic kidney disease (CKD) is highly prevalent in the general population, little research has been conducted on CKD management in ambulatory care. Objective was to assess management and quality of care by evaluating CKD coding in ambulatory care, patient diagnosis awareness, frequency of monitoring and whether appropriate patients are referred to nephrology. Methods: Clinical data from the population-based cohort Study of Health in Pomerania (SHIP-START) were matched with claims data of the Association of Statutory Health Insurance Physicians. Quality of care was evaluated according international and German recommendations. Results: Data from 1778 participants (56% female, mean age 59 years) were analysed. 10% had eGFR < 60 ml/min/1.73m2 (mean age 74 years), 15% had albuminuria. 21% had CKD as defined by KDIGO. 20% of these were coded and 7% self-reported having CKD. Coding increased with GFR stage (G3a 20%, G3b 61%, G4 75%, G5 100%). Serum creatinine and urinary dip stick testing were billed in the majority of all participants regardless of renal function. Testing frequency partially surpassed recommendations. Nephrology consultation was billed in few cases with stage G3b-G4. Conclusion: CKD coding increased with stage and was performed reliably in stages ≥ G4, while CKD awareness was low. Adherence to monitoring and referral criteria varied, depending on the applicability of monitoring criteria. For assessing quality of care, consent on monitoring, patient education, referral criteria and coordination of care needs to be established, accounting for patient related factors, including age and comorbidity. Trial registration: This study was prospectively registered as DRKS00009812 in the German Clinical Trials Register (DRKS).

21 May 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
HAHaitham Abaza
Haitham Abaza
ASAliaksandra Shutsko
Aliaksandra Shutsko
SKSophie A I Klopfenstein
Sophie A I Klopfenstein
CVCarina N Vorisek
Carina N Vorisek
CSCarsten Oliver Schmidt
Carsten Oliver Schmidt
MGMartin Golebiewski
Martin Golebiewski
Background: Despite wide acceptance in medical research, implementation of the FAIR (findability, accessibility, interoperability, and reusability) principles in certain health domains and interoperability across data sources remain a challenge. While clinical trial registries collect metadata about clinical studies, numerous epidemiological and public health studies remain unregistered or lack detailed information about relevant study documents. Making valuable data from these studies available to the research community could improve our understanding of various diseases and their risk factors. The National Research Data Infrastructure for Personal Health Data (NFDI4Health) seeks to optimize data sharing among the clinical, epidemiological, and public health research communities while preserving privacy and ethical regulations. Objective: We aimed to develop a tailored metadata schema (MDS) to support the standardized publication of health studies’ metadata in NFDI4Health services and beyond. This study describes the development, structure, and implementation of this MDS designed to improve the FAIRness of metadata from clinical, epidemiological, and public health research while maintaining compatibility with metadata models of other resources to ease interoperability. Methods: Based on the models of DataCite, ClinicalTrials.gov, and other data models and international standards, the first MDS version was developed by the NFDI4Health Task Force COVID-19. It was later extended in a modular fashion, combining generic and NFDI4Health use case–specific metadata items relevant to domains of nutritional epidemiology, chronic diseases, and record linkage. Mappings to schemas of clinical trial registries and international and local initiatives were performed to enable interfacing with external resources. The MDS is represented in Microsoft Excel spreadsheets. A transformation into an improved and interactive machine-readable format was completed using the ART-DECOR (Advanced Requirement Tooling-Data Elements, Codes, OIDs, and Rules) tool to facilitate editing, maintenance, and versioning. Results: The MDS is implemented in NFDI4Health services (eg, the German Central Health Study Hub and the Local Data Hub) to structure and exchange study-related metadata. Its current version (3.3) comprises 220 metadata items in 5 modules. The core and design modules cover generic metadata, including bibliographic information, study design details, and data access information. Domain-specific metadata are included in use case–specific modules, currently comprising nutritional epidemiology, chronic diseases, and record linkage. All modules incorporate mandatory, optional, and conditional items. Mappings to the schemas of clinical trial registries and other resources enable integrating their study metadata in the NFDI4Health services. The current MDS version is available in both Excel and ART-DECOR formats. Conclusions: With its implementation in the German Central Health Study Hub and the Local Data Hub, the MDS improves the FAIRness of data from clinical, epidemiological, and public health research. Due to its generic nature and interoperability through mappings to other schemas, it is transferable to services from adjacent domains, making it useful for a broader user community.

28 June 2024 in Journal of Open Source Software
Verified
Journal Article
Open access
PDF file
SSStephan Struckmann
Stephan Struckmann
JMJoany Mariño
Joany Mariño
EKElisa Kasbohm
Elisa Kasbohm
ESElena Salogni
Elena Salogni
CSCarsten Oliver Schmidt
Carsten Oliver Schmidt
DataquieR version 2 is a major update to the dataquieR package (Richter et al., 2021). It enables extensive, highly standardized, and accessible data quality assessments related to data integrity (such as data type errors or duplicates), completeness (for example, missing values), consistency (for instance, range violations or contradictions), and accuracy (such as time trends or examiner effects) on tabular form data. This update extends the coverage of data quality indicators from the underlying framework (Schmidt et al., 2021) based on a substantially improved information model. It furthermore comprises performance enhancements, interactive output, and versatile options to grade data quality issues. The broader framework coverage is achieved by integrating dataquieR 2 with a differentiated metadata schema. This spreadsheet-type schema includes descriptions, expectations and requirements about the following data objects in a machine-readable way: (1) single variables and data fields, (2) combinations of variables, (3) segments of the data, (4) data tables, (5) representation and classification of missing data, and (6) identifier codes. The new metadata schema makes additional assumptions underlying data quality assessments explicit, thereby improving reproducible data quality reporting in compliance with the FAIR (Findable, Accessible, Interoperable, and Reusable) principles (Wilkinson et al., 2016). While dataquieR has primarily been designed for observational health studies, such as population-based cohort studies (Peters et al., 2022; Schmidt et al., 2023), it can also be applied to all sorts of tabular data from other sources, for instance, electronic health record (EHR) data, or registries.

11 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MWMichael Weber
Michael Weber
PGPeter Gierschner
Peter Gierschner
AKAnne Klassen
Anne Klassen
EKElisa Kasbohm
Elisa Kasbohm
JSJochen Schubert
Jochen Schubert
HKHeike U Köhler
Heike U Köhler
Paratuberculosis is an important disease of ruminants caused by Mycobacterium avium ssp. paratuberculosis (MAP). Early detection is crucial for successful infection control, but available diagnostic tests are still dissatisfying. Methods allowing a rapid, economic, and reliable identification of animals or herds affected by MAP are urgently required. This explorative study evaluated the potential of volatile organic compounds (VOCs) to discriminate between cattle with and without MAP infections. Headspaces above fecal samples and alveolar fractions of exhaled breath of 77 cows from eight farms with defined MAP status were analyzed in addition to stable air samples. VOCs were identified by GC–MS and quantified against reference substances. To discriminate MAP-positive from MAP-negative samples, VOC feature selection and random forest classification were performed. Classification models, generated for each biological specimen, were evaluated using repeated cross-validation. The robustness of the results was tested by predicting samples of two different sampling days. For MAP classification, the different biological matrices emitted diagnostically relevant VOCs of a unique but partly overlapping pattern (fecal headspace: 19, alveolar gas: 11, stable air: 4–5). Chemically, relevant compounds belonged to hydrocarbons, ketones, alcohols, furans, and aldehydes. Comparing the different biological specimens, VOC analysis in fecal headspace proved to be most reproducible, discriminatory, and highly predictive.